Target-seeking antifibrotic compound enhances wound healing and suppresses scar formation in mice
- 24 November 2010
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 107 (50), 21671-21676
- https://doi.org/10.1073/pnas.1016233107
Abstract
Permanent scars form upon healing of tissue injuries such as those caused by ischemia (myocardial infarction, stroke), trauma, surgery, and inflammation. Current options in reducing scar formation are limited to local intervention. We have designed a systemically administered, target-seeking biotherapeutic for scar prevention. It consists of a vascular targeting peptide that specifically recognizes angiogenic blood vessels and extravasates into sites of injury, fused with a therapeutic molecule, decorin. Decorin prevents tissue fibrosis and promotes tissue regeneration by inhibiting TGF-β activity and by other regulatory activities. The decorin-targeting peptide fusion protein had substantially increased neutralizing activity against TGF-β1 in vitro compared with untargeted decorin. In vivo, the fusion protein selectively accumulated in wounds, and promoted wound healing and suppressed scar formation at doses where nontargeted decorin was inactive. These results show that selective targeting yields a tissue-healing and scar-reducing compound with enhanced specificity and potency. This approach may help make reducing scar formation by systemic drug delivery a feasible option for surgery and for the treatment of pathological processes in which scar formation is a problem.Keywords
This publication has 55 references indexed in Scilit:
- Hypertrophic Scar Formation Following Burns and Trauma: New Approaches to TreatmentPLoS Medicine, 2007
- A “traffic control” role for TGFβ3: orchestrating dermal and epidermal cell motility during wound healingThe Journal of cell biology, 2006
- A role for decorin in the remodeling of myocardial infarctionMatrix Biology, 2005
- Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiationThe FASEB Journal, 2005
- Perspective Article: Tissue repair, contraction, and the myofibroblastWound Repair and Regeneration, 2005
- Decorin Modulates Wound Healing in Experimental Glaucoma Filtration Surgery: A Pilot StudyInvestigative Ophthalmology & Visual Science, 2005
- Decorin Is a Biological Ligand for the Epidermal Growth Factor ReceptorPublished by Elsevier BV ,1999
- The Interaction of the Transforming Growth Factor-βs with Heparin/Heparan Sulfate Is Isoform-specificPublished by Elsevier BV ,1997
- Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases.Proceedings of the National Academy of Sciences of the United States of America, 1996
- Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor βBiochemical Journal, 1994